Covid-19 Response Debate
Full Debate: Read Full DebateJonathan Edwards
Main Page: Jonathan Edwards (Independent - Carmarthen East and Dinefwr)Department Debates - View all Jonathan Edwards's debates with the Department of Health and Social Care
(4 years, 3 months ago)
Commons ChamberI want to congratulate Wren Hall, because getting an outstanding rating is not easy, and it has done that. I congratulate every single member of staff, and I thank my hon. Friend for being a champion for them and bringing to my attention Wren Hall’s outstanding rating when it was received. The funding, of course, is a critical part of this. We put in £600 million extra on Friday, and as I said, that will all go direct to care homes—it is not to go into local authority budgets for onward consideration of passing to care homes; it is to get to the care homes. That will help with infection control, but we also have to ensure that funding is sustainable for the future.
Yesterday, the British Government announced in their daily briefing that they hope to have 30 million vaccines ready for use by September, yet on the same day, the Prime Minister wrote in The Mail on Sunday that there may never be a vaccine. Considering the way that Wales has been undermined by the British Government over the distribution of PPE and testing, what confidence can the people of Wales have that we will have our fair share of vaccines if one is developed?
It is not quite fair to say that Wales has not been served on PPE or testing. I have worked very closely with the Welsh Labour Government, and although the number of tests declared per day in Wales is low—it is only just over 1,000—there is access to UK-wide testing capabilities, such as home testing and the drive-through centres.
On the hon. Gentleman’s substantive point about the vaccine, I am delighted that we have been able to come to an agreement with AstraZeneca. If the science behind the Oxford vaccine works, it is likely to be one of the first available in the world, and we then have an agreement to ensure that 100 million doses are available for the UK, the first 30 million of which will be right at the start for the most vulnerable. That is a UK-wide policy—we will deliver it right across these islands. We should pay tribute to the work and the ingenuity of our scientists in Oxford and to the industrial might of AstraZeneca, who together, should they manage to pull off the science, will be able to deliver this vaccine to our population as we need it. Vaccine science is an uncertain business. That is why we cannot ever be 100% sure that there will be a safe and effective vaccine, but we are putting everything we can into making sure that we give them the best possible chance for every citizen of the whole United Kingdom.